News 23andMe weighing up sale of the company as cash runs dry Once boasting a valuation of $6bn, 23andMe is now worth $100m and struggling to stay afloat. Robert Barrie
Features Continuous glucose monitoring: the continuous uptake for easier diabetes management Robert Barrie
Features Genome sequencing at birth: sophisticated care or ethical nightmare? Chloe Kent and Chris Lo